The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Subscribe To Our Newsletter & Stay Updated